Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
Goethe University Frankfurt · Georg Speyer Haus · +7 more institutions
Abstract
Objective Investigating the effect of ferroptosis in the tumour microenvironment to identify combinatory therapy for liver cancer treatment. Design Glutathione peroxidase 4 (GPx4), which is considered the master regulator of ferroptosis, was genetically altered in murine models for hepatocellular carcinoma (HCC) and colorectal cancer (CRC) to analyse the effect of ferroptosis on tumour cells and the immune tumour microenvironment. The findings served as foundation for the identification of additional targets for combine therapy with ferroptotic inducer in the treatment of HCC and liver metastasis. Results Surprisingly, hepatocyte-restricted GPx4 loss does not suppress hepatocellular tumourigenesis. Instead,…
Citation impact
- FWCI
- 58.07
- Percentile
- 100%
- References
- 38
Authors
18- CCClaire Conche
Goethe University Frankfurt, Georg Speyer Haus, Frankfurt Cancer Institute
- FFFabian Finkelmeier
Goethe University Frankfurt, Georg Speyer Haus, Frankfurt Cancer Institute
- MPMarina Pešić
Goethe University Frankfurt, Georg Speyer Haus, Frankfurt Cancer Institute
- AMAdele M. Nicolas
Goethe University Frankfurt, Georg Speyer Haus, Frankfurt Cancer Institute
- TWTim W. Böttger
Goethe University Frankfurt, Georg Speyer Haus, Frankfurt Cancer Institute
Topics & keywords
- Cancer research
- Immune system
- Tumor microenvironment
- Medicine
- Immunology
- Metastasis
- Liver cancer
- Immune checkpoint
- Good health and well-being
Funding
- DFDeutsche ForschungsgemeinschaftAwards: SFB1292-Project ID: 318346496-TP16, SFB1479-Project ID: 441891347-P02, SFB1479, Gr1916/11-1, 441891347, GRK2336, SFB1292, 318346496, GRK 2336, FOR2438 Gr1916/11-1, FOR2438
- BFBundesministerium für Gesundheit
- HMHessisches Ministerium für Wissenschaft und KunstAward: III L 5 - 519/03/03.001 - (0015)